AbbVie's Wrinkle Drug Faces FDA Rejection Over Manufacturing Concerns

Pharmaceutical giant AbbVie has received a rejection from the U.S. Food and Drug Administration (FDA) regarding its new wrinkle drug, citing unresolved manufacturing issues.